SCHEMBL3851785

SCHEMBL3851785

Ic1cnc(N2CCNCC2)s1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HDAC2 Q92769 5/20 0.39
HDAC3 O15379 3/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNA4 P43681 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C18 P33260 1/20 0.39
CYP2C19 P33261 1/20 0.39
KCNH2 Q12809 1/20 0.39
ADRB2 P07550 1/20 0.38
AOC3 Q16853 1/20 0.38
PLD1 Q13393 1/20 0.37
SCN4A P35499 2/20 0.37
SCN9A Q15858 2/20 0.37
HDAC1 Q13547 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2628928 0.79 CHRNB2 (0.47) ALDH1A1KDM4ECHRNB2CHRNA4ADRB2
SCHEMBL9942581 0.78 ALDH1A1 (0.40) ALDH1A1KDM4EHDAC2HDAC3CHRNB2
SCHEMBL2629382 0.78 DPP4 (0.44) ALDH1A1KDM4ECHRNB2CHRNA4ADRB2
SCHEMBL3161903 0.78 ADRB2 (0.46) ALDH1A1KDM4ECHRNB2CHRNA4CYP1A2
SCHEMBL13044769 0.78 SMN1; SMN2 (0.48) ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL27237950 0.76 ADRB2 (0.44) ALDH1A1KDM4ECHRNB2CHRNA4CYP1A2
SCHEMBL7231518 0.75 ALDH1A1 (0.70) ALDH1A1KDM4EHDAC2HDAC3CHRNB2
SCHEMBL2828462 0.74 KDR (0.53) ALDH1A1KDM4E
SCHEMBL2828246 0.74 MLYCD (0.47)
SCHEMBL28198368 0.74 OGA (0.45) ALDH1A1KDM4EHDAC2HDAC3CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099755-A2 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS Glenmark Pharmaceuticals S.A. (CH) 2009-09-16 EP disclosed
US-20080182851-A1 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2008-07-31 US disclosed
WO-2008062276-A2 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (US) 2008-05-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182851-A1 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS SCD, SCD5, ACACA ALDH1A1 578/4885KDM4E 1815/4885HDAC2 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.